SGLT2i Integration Across Heart Failure

CE / CME

“How Do We Practically Do This?” Expert Guidance and Interactive Practice on SGLT2i Integration Across the Spectrum of Heart Failure

Physician Assistants/Physician Associates: 1.50 AAPA Category 1 CME credits

Nurses: 1.50 Nursing contact hours

Physicians: maximum of 1.50 AMA PRA Category 1 Credits

Released: December 11, 2024

Expiration: December 10, 2025

Javed Butler
Javed Butler, MD, MPH, MBA
Lauren S. Eyadiel
Lauren S. Eyadiel, MS, MMS, PA-C, SLP, FHFSA
Ty J. Gluckman
Ty J. Gluckman, MD, MHA

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

In a meta-analysis of DELIVER and EMPEROR-Preserved, use of an SGLT2i in patients with HFpEF showed significant reductions in CV death and first HF hospitalization in:

2.

How often do you currently use a rapid sequencing approach when initiating medications in patients with heart failure?

3.

When discussing SGLT2 inhibitor initiation in a patient with heart failure, which of the following counseling points should you provide? SGLT2 inhibitors . . .